I am a staff writer covering healthcare. Email me at [email protected]

Telehealth company Amwell surged in its first day of trading, exemplifying how hungry both the public and private markets are to invest in the sector whose growth has accelerated due to the coronavirus pandemic. Teladoc has reigned supreme the past few years as one of the only public telehealth companies, but its first-mover advantage is about to be put to the test. Exits of smaller competitors are starting to ramp up, thanks to venture capitalists pouring more than $1 billion into the sector so far this year, nearly three times what was invested in the same period last year…Keep Reading